Importantly, analysis of genetic alterations from different cancer genome sequencing studies using cBioportal [20,21] revealed that KEAP1/NFE2L2 mutations are highly frequent in NSCLC, endometrial cancer, ovarian cancer, nerve sheath tumor and various forms of squamous cell carcinoma including cervical cancer. Here, KEAP1 is linked to cancer.